Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer
Ruoyan Li(Northeast Agricultural University), Thomas J. Mitchell(University of Cambridge), Lira Mamanova(Wellcome Sanger Institute), Peter J. Campbell(Wellcome Sanger Institute), Kevin W. Loudon(University of Cambridge), Sarah A. Teichmann(Stem Cell Institute), Sarah J. Welsh(Royal Devon & Exeter NHS Foundation Trust), Liam Bolt(Wellcome Sanger Institute), Francesc Muyas(European Bioinformatics Institute), John R. Ferdinand(University of Cambridge), Joana B. Neves(The Royal Free Hospital), Anne Y. Warren(Cambridge University Hospitals NHS Foundation Trust), Thomas R. W. Oliver(Cambridge University Hospitals NHS Foundation Trust), Timothy Butler(Wellcome Sanger Institute), Sam Behjati(University of Cambridge), Eirini S. Fasouli(Wellcome Sanger Institute), Andrew Lawson(Wellcome Sanger Institute), Yvette Hooks(Wellcome Sanger Institute), Maxine Tran(The Royal Free Hospital), Grant D. Stewart(University of Cambridge), Menna R. Clatworthy(MRC Laboratory of Molecular Biology), Sean Laidlaw(Wellcome Sanger Institute), Georgina Bowyer(University of Cambridge), Matthew D. Young(Wellcome Sanger Institute), Isidro Cortés‐Ciriano(European Bioinformatics Institute), James N. Armitage(Cambridge University Hospitals NHS Foundation Trust), Kerstin B. Meyer(Siriraj Hospital), Tev Aho(Cambridge University Hospitals NHS Foundation Trust), Antony C. P. Riddick(Cambridge University Hospitals NHS Foundation Trust), Vincent J. Gnanapragasam(Addenbrooke's Hospital)
Cited by 251
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k